Response to litigation
Wed 24th February 2016
Oxford Nanopore Technologies, the UK-based company that sells the only nanopore sequencing device, the MinIONportable DNA sequencer and is developing the high throughput/ high sample number PromethIONdevice, responds to the patent lawsuit filed by Illumina, Inc.
Dr Gordon Sanghera, CEO of Oxford Nanopore said “It is gratifying to have the commercial relevance of Oxford Nanopore products so publicly acknowledged by the market monopolist for NGS.”
We do not anticipate any disruption to our ongoing commercial progress as a result of Illumina’s action, which we believe is without merit.
Register an account to start using MinION
Review MinION publications
Oxford Nanopore’s Intellectual Property portfolio